Investment Summary

TPG Invests In 8990 Holdings

On May 14, 2014, private equity firm TPG invested in real estate company 8990 Holdings

Investment Highlights
  • This is TPG’s 6th transaction in the Real Estate sector.
  • This is TPG’s 1st transaction in Philippines.

Investment Summary

Date 2014-05-14
Target 8990 Holdings
Sector Real Estate
Investor(s) TPG
Deal Type Stake Purchase

Target

8990 Holdings

Mandaluyong City, Philippines
8990 Holdings is a mass housing developer in the Philippines.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

TPG

Fort Worth, Texas, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1992
PE ASSETS 296.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.


DEAL STATS #
Overall 234 of 451
Sector: Real Estate M&A 6 of 12
Type: Stake Purchase M&A Deals 21 of 37
Country: Philippines M&A 1 of 2
Year: 2014 M&A 10 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-05-08 Alder Biopharmaceuticals

Bothell, Washington, United States

Alder Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel antibodies that originate from its proprietary platform for the production of antibodies in picchia. Alder Biopharmaceuticals was formed in 2002 and is based in Bothell, Washington.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-05-21 Roka Bioscience

Warren, New Jersey, United States

Roka Bioscience is a molecular pathogen detection company. The company has exclusive access to GenProbe's Transcription Mediated Amplification technology for detecting RNA as applied to industrial uses and some point of care diagnostic applications.

Sell -